Formulation Development
COVID-19’s Effect Will Boost Infectious Disease Drug Approvals & Present Opportunities to CMOs
In response to the global pandemic, biopharma companies have put a renewed emphasis on finding treatments for infectious diseases, including COVID-19 and other infectious diseases overall…..
Akers Biosciences & Premas Biotech Announce Successful Completion of COVID-19 Vaccine Prototype & Obtained First Images of VLP
Akers Biosciences, Inc. recently announced that Premas Biotech, its partner in the development of a vaccine candidate that is seeking to address the COVID-19 pandemic…..
Santhera Signs Agreements in Gene Therapy Research With Rutgers University
Santhera Pharmaceuticals recently announced the signing of two agreements with Rutgers, The State University of New Jersey as part of its program to advance gene…
Rubius Therapeutics Announces Dosing of First Patient in Phase 1/2 Trial
Rubius Therapeutics, Inc. recently announced that the first patient has been dosed in its Phase 1/2 clinical trial of RTX-240 for the treatment of patients…
Catalent Partners With Humanigen to Support FDA-Approved Phase 3 Lenzilumab Study for COVID-19
Catalent recently welcomed the news by Humanigen, Inc., that it has dosed the first COVID-19 patient in its previously announced Phase 3 study for lenzilumab,…
Evelo Biosciences, Rutgers University & Robert Wood Johnson University Hospital Announce Submission of IND for Phase 2 Study of EDP1815 in COVID-19 Patients
Evelo Biosciences, Inc., Rutgers University, and Robert Wood Johnson University Hospital recently announced the submission of an Investigational New Drug (IND) application for an Evelo-sponsored…
AI VIVO Seeks Collaboration Partners to Progress Top-Ranked COVID-19 Therapeutic Candidates
AI VIVO recently announced it is seeking pharma and biotech collaboration partners to progress therapeutic candidates that have been identified by the company as “top-ranked”…
Fortress Biotech Announces Exclusive Worldwide License Agreement With Columbia University
Fortress Biotech, Inc. recently announced that Oncogenuity, Inc. has entered into an exclusive worldwide licensing agreement with Columbia University to develop novel….
Daré Bioscience & Health Decisions Form Strategic Partnership
Daré Bioscience, Inc. recently announced that the companies have signed a partnership agreement under which Health Decisions will exclusively provide….
Evonik Commissions Advanced Biomaterials Production Facility for Pharmaceutical & Medical Applications
Evonik recently announced the successful commissioning of an advanced biomaterials facility in Birmingham, AL, that will support the increasing global market demand for….
Singota Solutions Collaborates With Noveome Biotherapeutics to Manufacture Promising Therapy to Treat Severe Condition in People Infected with COVID-19
Singota Solutions has been selected to collaborate with Noveome Biotherapeutics, Inc. to manufacture the ST266 investigational drug product, a biologic being evaluated in….
Proveris Scientific Announces its Laboratory Compliance With cGMP
Proveris Scientific Corporation, a leading provider of services and technology to advance the science of spray and aerosol products, recently announced it is expanding its…
Proveris Scientific Announces Contract Test Services to Support Development of SARS-CoV-2 (COVID-19) Inhaled Drug Therapies & Vaccines
Proveris Scientific Corporation, a leading provider of services and technology to advance the science of spray and aerosol products, recently announced the availability of contract test services to support….
Starton Therapeutics Files PCT & US Patent Application for Continuous Delivery of Lenalidomide & Class of Immunomodulatory Agents
Starton Therapeutics Inc. recently announced it has filed PCT (Patent Cooperation Treaty) and US Non-Provisional patent applications entitled Continuous Delivery of Lenalidomide and Other Immunomodulatory…
TG Therapeutics Announces Publication of Ublituximab Phase 2 Clinical Trial Results
TG Therapeutics, Inc. recently announced the publication of results from the multicenter Phase 2 trial evaluating ublituximab, the Company’s investigational, glycoengineered, anti-CD20 monoclonal antibody, in…
Catalent Announces Next Generation of Cell & Gene Therapy Leadership
Catalent, Inc. recently announced the appointment of Manja Boerman, PhD, to the role of President, Cell & Gene Therapy, effective June 1, 2020. In this…
Aravive & WuXi Biologics Form Strategic Collaboration to Develop Novel High-Affinity Bispecific Antibodies
Aravive, Inc. and WuXi Biologics recently announced a strategic collaboration agreement granting Aravive the right to use the proprietary WuXiBody platform to develop high-affinity bispecific…
TTP Collaborates With ODx to Develop New Technology to Address Antibiotic Resistance
TTP plc recently announced it has partnered with ODx (ODx Innovations Ltd), a company committed to developing a system for assessing urinary tract infections (UTIs).…
FDA Approves FENSOLVI for Injectable Suspension for Pediatric Patients with Central Precocious Puberty
Tolmar Pharmaceuticals, Inc. recently announced the US FDA has approved its New Drug Application for FENSOLVI (leuprolide acetate) for injectable suspension for the treatment of…
Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership With CytoDyn
Ajinomoto Bio-Pharma Services recently announced it has entered into a manufacturing services agreement with CytoDyn Inc., a late stage biotechnology company, for the supply of the investigational new drug….
